Enhancement of apoptotic susceptibility in human endometrial epithelial cell line HHUA by transforming growth factor-β1

Hormone and Metabolic Research

Volumn 30, Issue 2, 1998, Pages 61-65

  Tanaka, T ^a   Umesaki, N ^a   Mizuno, K ^a   Chang, L ^a   Miyama, M ^a   Ohtaki, S ^b   Ogita, S ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Apoptosis; Endometrial carcinoma; Endometrium; Fas; TGF 1

Indexed keywords

DNA FRAGMENT; FAS ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0031884559     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978835     Document Type: Article

References (24)

1. Alam R, Forsythe P, Stafford S, Fukuca Y. Transforming growth factor beta abrogates the effects of hematopoietins on eosinophilsand induces their apoptosis. J Exp Med 1994; 179: 1041-5
2. Bruner KL, Rodgers WH, Gold LI, Korc M, Hargrove JT, Matrisian LM, Osteen KG. Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci USA 1995; 92: 7362-6
3. Cerwenka A, Kovar H, Majdic O, Holter W. Fas-and activation-induced apoptosis are reduced in human T-cells preactivated in the presence of TGF-beta 1. J Immunol 1996; 156: 459-64
4. de Boer WI, Rebel JM, Vermey M, de Jong AA, van der Kwast TH. Characterization of distinct functions for growth factors in murine transitional epithelial cells in primary organotypic culture. Exp Cell Res 1994; 214: 510-8
5. Dore JJ Jr, Wilkinson JE, Godkin JD. Ovine endometrial expression of transforming growth factor beta isoforms during the peri-implantation period. Biol. Reprod. 1996; 54: 1080-7
6. Dumont N, O'Conner-McCourt MD, Philip A. Transforming growth factor-beta receptors on human endometrial cells: Identification of the type I, II, and III receptors and glycosy-phosphatidylinositol anchored TGF-beta binding proteins. Mol Cell Endocrinol 1995; 111: 57-66
7. Gold LI, Saxena B, Mittal KR, Marmor M, Goswami S, Nactical L, Kork M, Demopoulos RI. Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. Cancer Res 1994; 54: 2347-58
8. Gompel A, Sabourin JC, Martin A, Yaneva H, Audouin J, Decroix Y, Poitout P. Bcl-2 expression in normal endometrium during the menstrual cycle. Amer J Pathol 1994; 144: 1195-1202
9. Ishiwata I, Ishiwata C, Soma M, Arai J, Ishikawa H. Establishment of human endometrial adenocarcinoma cell line containing estradiol-17β and progesterone receptors. Gynecologic Oncol 1984; 17: 281-90
10. Kamijo T, Rajabi MR. Biochemical evidence for the occurrence of apoptosis in uterine endometrial epithelial cells at implantation of mouse embryos in vitro. J Soc Gynecol Invest 1996; 3: 208 A
11. Kanzaki H, Hatayama H, Narukawa S, Kariya M, Fujita J, Mori T. Hormonal regulation in the production of macrophage colony-stimulating factor and transforming growth factor-beta by human endometrial stromal cells in culture. Horm Res 1995; 44: 30-5
12. Kauma S, Matt D, Strom S, Eierman D, Turner T. Interleukin-1β, human leukocyte antigen HLA-DRa, and transforming growth factor-b expression in endometrium, placenta, and placental membranes. Am J Obstet Gynecol 1990; 163: 130-7
13. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Kawabe Y, Aoyagi T, Nagataki S. Inhibition of Fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor beta 1. Arthritis Rheum 1996; 39: 1267-76
14. Kokawa K, Shikone T, Nakano R. Apoptosis in the human uterine endometrium during the menstrual cycle. J Clin Endocrin Metab 1996; 81: 4144-47
15. Lennard SN, Stewart F, Allen WR. Transforming growth factor beta 1 expression in the endometrium of the mare during placentation. Mol Reprod Dev 1995; 42: 131-40
16. Lomo J, Blomhoff HK, Beiske K, Stokke T, Smeland EB. TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J Immunol 1995; 154: 1634-43
17. Moulton BC. Transforming growth factor-beta stimulates endometrial stromal apoptosis in vitro. Endocrinology 1994; 134: 1055-60
18. Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W, Schulte-Hermann R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc Natl Acad Sci USA 1992; 89: 5408-12
19. Otsuki Y, Misaki O, Sugimoto O, Ito Y, Tsujimoto Y, Akao Y. Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle. Lancet 1994; 344: 28-9
20. Tabibzadeh S, Babaknia A, Liu R, Zupi E, Marconi D, Romanini C. Site and menstrual cycle-dependent expression of proteins of the TNS receptor family, and BCL-2 oncoprotein and phase specific production of TNF-α in human endometrium. Human Reprod 1994; 10: 277-86
21. Tabibzadeh S. Signals and molecular pathways involved in apoptosis, with special emphasis on human endometrium. Human Reprod Update 1995; 1: 303-23
22. Tang XM, Zhao Y, Rossi MJ, Abu-Rustum RS, Ksander GA, Chegini N. Expression of transforming growth factor β (TFG β) isoforms and TGF-β type II receptor messenger ribonucleic acid and protein, and the effect of TGF βs on endometrial stromal cell growth and protein degradation in vitro. Endocrinology 1994; 135: 450-9
23. Tsukada T, Eguchi K, Migita K, Kawabe Y, Kawakami A, Matsuoka N, Takashima H, Mizokami A, Nagataki S. Transforming growth factor beta 1 induces apoptotic cell death in cultured human umbilical vein endothelial cells with down-regulated expression of bcl-2. Biochem Biophys Res Commun 1995; 210: 1076-82
24. Yamashita H, Kumagai K, Inoki C, Ueki M, Sugimoto O, Otsuki Y. The expression of Fas antigen in human endometrium. Acta Obstet Gynecol Jpn 1995; 47: 277-8